By Pam Belluck
July 25, 2018

See Original Post


The long, discouraging quest for a medication that works to treat
Alzheimer's reached a potentially promising milestone on Wednesday. For the
first time in a large clinical trial, a drug was able to both reduce the
plaques in the brains of patients and slow the progression of dementia.


More extensive trials will be needed to know if the new drug is truly
effective, but if the results, presented Wednesday at the Alzheimer's
Association International Conference in Chicago, are borne out, the drug may
be the first to successfully attack both the brain changes and the symptoms
of Alzheimer's.